Baltimore, MD, United States of America

Ronald K Mann

This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2010.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ronald K Mann

Introduction

Ronald K Mann is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical research, particularly in the development of compounds that target the WNT signaling pathway. His work has implications for treating various diseases and pathologies.

Latest Patents

Mann holds a patent for "WNT pathway antagonists," which involves aromatic compounds designed for treating various diseases. The methods associated with these compounds provide innovative approaches to inhibit aberrant growth states in cells that possess Wnt receptors. This patent highlights his commitment to advancing medical science through innovative solutions.

Career Highlights

Mann is affiliated with Johns Hopkins University, where he continues to engage in groundbreaking research. His work at this prestigious institution has allowed him to explore new frontiers in the medical field, contributing to the understanding and treatment of complex diseases.

Collaborations

Mann has collaborated with esteemed colleagues such as James K Chen and Philip Arden Beachy. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries in their shared field of research.

Conclusion

Ronald K Mann's contributions to the field of medical research through his patent on WNT pathway antagonists exemplify the impact of innovation in treating diseases. His work at Johns Hopkins University and collaborations with other experts further underscore his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…